版本:
中国

BRIEF-Forward Pharma appeals initial decision in U.S. patent interference to federal circuit

May 31 Forward Pharma A/S:

* Forward Pharma appeals the initial decision in the U.S. patent interference to the federal circuit

* Forward Pharma - filing of notice of appeal of PTAB decision that ended interference proceeding between forward 11/576,871 patent application and an issued Biogen patent

* Says appeal is expected to last ten months or longer Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐